Cheriyath V - Search Results

1

G1P3/IFI6, an interferon stimulated protein, promotes the association of RAB5⁺ endosomes with mitochondria in breast cancer cells.

Davenport AM, Morris M, Sabti F, Sabti S, Shakya D, Hynds DL, Cheriyath V. Davenport AM, et al. Among authors: cheriyath v. Cell Biol Int. 2023 Nov;47(11):1868-1879. doi: 10.1002/cbin.12079. Epub 2023 Aug 20. Cell Biol Int. 2023. PMID: 37598317

2

G1P3 (IFI6), a mitochondrial localised antiapoptotic protein, promotes metastatic potential of breast cancer cells through mtROS.

Cheriyath V, Kaur J, Davenport A, Khalel A, Chowdhury N, Gaddipati L. Cheriyath V, et al. Br J Cancer. 2018 Jul;119(1):52-64. doi: 10.1038/s41416-018-0137-3. Epub 2018 Jun 14. Br J Cancer. 2018. PMID: 29899394 Free PMC article.

3

Epigenome modulated xenobiotic detoxification pathways control DMBA-induced breast cancer in agouti A^vy/a mice.

Mazambani S, Morris M, Cheriyath V. Mazambani S, et al. Among authors: cheriyath v. Epigenetics. 2019 Jul;14(7):708-720. doi: 10.1080/15592294.2019.1610306. Epub 2019 May 9. Epigenetics. 2019. PMID: 31070092 Free PMC article.

4

Loss of Maspardin Attenuates the Growth and Maturation of Mouse Cortical Neurons.

Davenport A, Bivona A, Latson W, Lemanski LF, Cheriyath V. Davenport A, et al. Among authors: cheriyath v. Neurodegener Dis. 2016;16(3-4):260-72. doi: 10.1159/000443666. Epub 2016 Mar 16. Neurodegener Dis. 2016. PMID: 26978163

5

G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer.

Cheriyath V, Kuhns MA, Jacobs BS, Evangelista P, Elson P, Downs-Kelly E, Tubbs R, Borden EC. Cheriyath V, et al. Oncogene. 2012 Apr 26;31(17):2222-36. doi: 10.1038/onc.2011.393. Epub 2011 Sep 26. Oncogene. 2012. PMID: 21996729

6

Glycone-rich Soy Isoflavone Extracts Promote Estrogen Receptor Positive Breast Cancer Cell Growth.

Johnson KA, Vemuri S, Alsahafi S, Castillo R, Cheriyath V. Johnson KA, et al. Among authors: cheriyath v. Nutr Cancer. 2016 May-Jun;68(4):622-33. doi: 10.1080/01635581.2016.1154578. Epub 2016 Apr 4. Nutr Cancer. 2016. PMID: 27043076

7

G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells.

Cheriyath V, Glaser KB, Waring JF, Baz R, Hussein MA, Borden EC. Cheriyath V, et al. J Clin Invest. 2007 Oct;117(10):3107-17. doi: 10.1172/JCI31122. J Clin Invest. 2007. PMID: 17823654 Free PMC article.

8

Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies.

Khan SN, Jankowska AM, Mahfouz R, Dunbar AJ, Sugimoto Y, Hosono N, Hu Z, Cheriyath V, Vatolin S, Przychodzen B, Reu FJ, Saunthararajah Y, O'Keefe C, Sekeres MA, List AF, Moliterno AR, McDevitt MA, Maciejewski JP, Makishima H. Khan SN, et al. Among authors: cheriyath v. Leukemia. 2013 Jun;27(6):1301-9. doi: 10.1038/leu.2013.80. Epub 2013 Mar 14. Leukemia. 2013. PMID: 23486531

9

Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest.

Vijayaraghavalu S, Dermawan JK, Cheriyath V, Labhasetwar V. Vijayaraghavalu S, et al. Among authors: cheriyath v. Mol Pharm. 2013 Jan 7;10(1):337-52. doi: 10.1021/mp3004622. Epub 2012 Dec 24. Mol Pharm. 2013. PMID: 23215027 Free PMC article.

10

Potentiation of apoptosis by histone deacetylase inhibitors and doxorubicin combination: cytoplasmic cathepsin B as a mediator of apoptosis in multiple myeloma.

Cheriyath V, Kuhns MA, Kalaycio ME, Borden EC. Cheriyath V, et al. Br J Cancer. 2011 Mar 15;104(6):957-67. doi: 10.1038/bjc.2011.42. Epub 2011 Mar 1. Br J Cancer. 2011. PMID: 21364585 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page